Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple traction table ease chronic back pain in obesity?

NCT ID NCT04507074

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at whether lumbar traction therapy (a device that gently pulls on the spine) can reduce pain and improve function in people with obesity and chronic low back pain. 49 participants received 30 minutes of traction daily for 4 weeks. Researchers measured pain, disability, and blood markers of spinal damage before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lumbar traction therapy (device)
What this could lead to
If successful, this could point toward a non-drug treatment option for chronic low back pain in people with obesity.
What could go wrong
This is a small, completed study with only 49 participants, so results may not apply to everyone. The therapy is short-term and effects may not last.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

49 people

The number who actually took part.

Started

Sep 2020

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Written consent to participate in the study, 2. Age: 35 - 60 years, 3. Obesity (BMI ≥ 30 kg / m2) or normal weight (BMI 18,5-29,9 kg/m2), 4. Stable body weight in the last month ± 2 kg, 5. Chronic low back pain. Exclusion Criteria: 1. Secondary form of obesity; 2. Serious neurological defects (including large muscle losses, sensory disturbances in a large area of the lower limb, occurrence of cauda equina syndrome); 3. Surgery, post-accident mechanical injuries, history of spine fractures; 4. History of rheumatic disease (RA, ankylosing spondylitis, systemic lupus); 5. Osteoporosis; 6. Pain located in a location other than the spine which is more severe than the low back pain; 7. Poorly controlled type 2 diabetes; 8. Poorly controlled hypertension (mean systolic blood pressure\> 140mmHg and / or average diastolic blood pressure\> 90mmHg) during the last month and / or the necessity of modification of pharmacological treatment; 9. Lipid disorders requiring the introduction of pharmacological treatment in the last 3 months before observation or during observation; 10. Acute coronary event, unstable angina, stroke or transient cerebral ischemia in the last 6 months; 11. Features of heart failure in physical examination and / or additional tests (chest X-ray, echocardiography); 12. Clinically significant arrhythmias, conduction disorders, pacemaker implantation; 13. Fainting in an interview, 14. Chronic kidney disease with creatinine clearance \<60mL / min / 1.73m2; 15. Clinically significant liver dysfunction (transaminases exceeding 3 times the normal range); 16. Acute or chronic, clinically apparent inflammatory process of the respiratory tract, inflammatory processes of the genitourinary system, inflammatory process in the head and neck; 17. Acute infection in the last month; 18. Cancer; 19. Alcohol abuse, drug addiction; 20. Pregnancy; 21. Uncontrolled mental illness that may falsify test results; 22. Other conditions which may pose any risk to the patient during the observation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Poznan University of Physical Education

    Poznan, 61-871, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.